AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2647907 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose bromocriptine (less than 30 mg/day)
Number of subjects: 129
Study 2647907 — intervention group
Group type: COMPARATOR
Intervention: Low-dose levodopa-carbidopa (less than 600/150 mg/day)
Number of subjects: 129
Study 30987594 — intervention group
Group type: EXPERIMENTAL
Intervention: Premedication with flunitrazepam
Number of subjects: 50
Study 30987594 — intervention group
Group type: EXPERIMENTAL
Intervention: Prewarming using an underbody forced-air warming blanket
Number of subjects: 50
Study 30987594 — intervention group
Group type: COMPARATOR
Intervention: Control group (no prewarming)
Number of subjects: 50
Study 30987594 — intervention group
Group type: EXPERIMENTAL
Intervention: Prewarming
Number of subjects: 50
Study 28466507 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH diet
Number of subjects: 60
Study 26228333 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery (Group A)
Number of subjects: 337
Study 26228333 — intervention group
Group type: COMPARATOR
Intervention: Conventional mesh repair (Group B)
Number of subjects: 337
Study 23138693 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative treatment
Number of subjects: 20
Study 23138693 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment
Number of subjects: 20
Study 20568433 — intervention group
Group type: EXPERIMENTAL
Intervention: Herb-partitioned spread moxibustion
Number of subjects: 60
Study 20568433 — intervention group
Group type: COMPARATOR
Intervention: Oral administration of Sulfasalazine
Number of subjects: 60
Study 18173345 — intervention group
Group type: EXPERIMENTAL
Intervention: Microendoscopic discectomy (MED)
Number of subjects: 15
Study 18173345 — intervention group
Group type: COMPARATOR
Intervention: Microscopic discectomy (MD)
Number of subjects: 15
Study 16891998 — intervention group
Group type: EXPERIMENTAL
Intervention: Moclobemide and supportive guidance
Number of subjects: 81
Study 16891998 — intervention group
Group type: EXPERIMENTAL
Intervention: Group cognitive-behavioral therapy (CBT) and pill placebo
Number of subjects: 81
Study 16891998 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of moclobemide and group cognitive-behavioral therapy
Number of subjects: 81
Study 16891998 — intervention group
Group type: COMPARATOR
Intervention: Control group (pill placebo)
Number of subjects: 81
Study 16891998 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT (during 24-month follow up)
Number of subjects: 81
Study 14691773 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid artery stenting (CAS)
Number of subjects: 0
Study 14691773 — intervention group
Group type: COMPARATOR
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 0
Study 14691773 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparisons between CAS and CEA
Number of subjects: 0
Study 10899408 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolmitriptan
Number of subjects: 30
Study 10899408 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan
Number of subjects: 30
Study 10899408 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 8676185 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuing education seminars (3 seminars over 4 months)
Number of subjects: 5685
Study 2049967 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin (OFX) treatment
Number of subjects: 0
Study 2049967 — intervention group
Group type: COMPARATOR
Intervention: Combination treatment with Ofloxacin (OFX) and a single dose of aminoglycoside (isepamicin)
Number of subjects: 0
Study 6128447 — intervention group
Group type: EXPERIMENTAL
Intervention: Food intolerance challenge (double blind)
Number of subjects: 21
Study 6128447 — intervention group
Group type: EXPERIMENTAL
Intervention: Challenge foods
Number of subjects: 21
Study 6128447 — intervention group
Group type: COMPARATOR
Intervention: Control foods
Number of subjects: 21
Study 6128447 — intervention group
Group type: EXPERIMENTAL
Intervention: Food intolerance
Number of subjects: 21
Study 6128447 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal PGE2
Number of subjects: 21
Study 31663671 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective course on preliminary structural biology, duration 15 weeks, involving cloning, expression, purification, and crystal screening of HpaA.
Number of subjects: 18
Study 31575591 — intervention group
Group type: EXPERIMENTAL
Intervention: Thirst intervention performed by nurses
Number of subjects: 136
Study 31575591 — intervention group
Group type: EXPERIMENTAL
Intervention: Thirst intervention performed by family members
Number of subjects: 136
Study 31575591 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse and family member burden levels
Number of subjects: 136
Study 28662152 — intervention group
Group type: EXPERIMENTAL
Intervention: External pneumatic compression (EPC)
Number of subjects: 20
Study 28662152 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 20
Study 26425078 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% experimental load
Number of subjects: 20
Study 26425078 — intervention group
Group type: EXPERIMENTAL
Intervention: 80% experimental load
Number of subjects: 20
Study 26425078 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 20
Study 23438803 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mL 2% articaine (Group A)
Number of subjects: 60
Study 23438803 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mL 2% articaine + 10 mL 0.75% ropivacaine (Group AR)
Number of subjects: 60
Study 23438803 — intervention group
Group type: COMPARATOR
Intervention: 20 mL 0.75% ropivacaine (Group R)
Number of subjects: 60
Study 21543543 — intervention group
Group type: EXPERIMENTAL
Intervention: Early nutrition program with varying diets during the neonatal period (no phosphate supplements provided)
Number of subjects: 20
Study 21543543 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher proportion of unsupplemented human milk in the neonatal diet
Number of subjects: 20
Study 21543543 — intervention group
Group type: COMPARATOR
Intervention: Preterm subjects compared to population reference data
Number of subjects: 20
Study 19375574 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary Distress Inventory (UDI)
Number of subjects: 0
Study 19375574 — intervention group
Group type: EXPERIMENTAL
Intervention: UDI‐stress subscale of the Pelvic Floor Distress Inventory
Number of subjects: 0
Study 19375574 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary Impact Questionnaire (UIQ)
Number of subjects: 0
Study 16959618 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium 18 microg once daily from a dry powder inhaler (HandiHaler)
Number of subjects: 132
Study 16959618 — intervention group
Group type: COMPARATOR
Intervention: Ipratropium 20 microg four times daily from a metered dose inhaler
Number of subjects: 132
Study 15221622 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-administration of CR L-dopa and entacapone
Number of subjects: 10
Study 15221622 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed administration of entacapone (30 and 90 minutes) with CR L-dopa
Number of subjects: 10
Study 11299402 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral sphincterotomy under local anesthesia (topical anesthetic cream xylocaine 2% and local anesthesia)
Number of subjects: 62
Study 11299402 — intervention group
Group type: COMPARATOR
Intervention: Lateral sphincterotomy under general anesthesia
Number of subjects: 62
Study 9390597 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 1 mg/kg
Number of subjects: 40
Study 9390597 — intervention group
Group type: COMPARATOR
Intervention: Thiopental 4 mg/kg
Number of subjects: 40
Study 8433253 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided tissue regeneration with tetracycline root conditioning (100 mg/ml)
Number of subjects: 18
Study 8433253 — intervention group
Group type: COMPARATOR
Intervention: Guided tissue regeneration with membrane alone (control)
Number of subjects: 18
Study 3677365 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded symptom-limited bicycle exercise testing
Number of subjects: 607
Study 3677365 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambulatory electrocardiographic monitoring
Number of subjects: 607
Study 30558607 — intervention group
Group type: EXPERIMENTAL
Intervention: Per oral (p.o.) antibiotic monotherapy
Number of subjects: 552
Study 30558607 — intervention group
Group type: COMPARATOR
Intervention: Intravenous (i.v.) antibiotic therapy followed by p.o. antibiotics
Number of subjects: 552
Study 26809111 — intervention group
Group type: EXPERIMENTAL
Intervention: DEB-TACE plus sorafenib 400 mg twice daily
Number of subjects: 307
Study 26809111 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus DEB-TACE
Number of subjects: 307
Study 24997825 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposome-paclitaxel plus carboplatin (LPC)
Number of subjects: 54
Study 24997825 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel plus carboplatin (PC)
Number of subjects: 54
Study 22848896 — intervention group
Group type: EXPERIMENTAL
Intervention: Inward-inclined platform implants
Number of subjects: 40
Study 22848896 — intervention group
Group type: COMPARATOR
Intervention: Traditional external-hexagon implants
Number of subjects: 40
Study 22848896 — intervention group
Group type: COMPARATOR
Intervention: Control group (external-hexagon implants)
Number of subjects: 40
Study 22848896 — intervention group
Group type: EXPERIMENTAL
Intervention: Test group (inward-inclined platform implants)
Number of subjects: 40
Study 20694297 — intervention group
Group type: EXPERIMENTAL
Intervention: Soybean protein formula
Number of subjects: 50
Study 20694297 — intervention group
Group type: COMPARATOR
Intervention: Casein protein formula
Number of subjects: 50
Study 17287681 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-eluting stents (DES) technology
Number of subjects: 0
Study 17287681 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailor-made strategy for each patient
Number of subjects: 0
Study 15762389 — intervention group
Group type: EXPERIMENTAL
Intervention: Petting a live dog (Group 1)
Number of subjects: 55
Study 15762389 — intervention group
Group type: COMPARATOR
Intervention: Petting a stuffed dog (Group 2)
Number of subjects: 55
Study 15762389 — intervention group
Group type: COMPARATOR
Intervention: Sitting comfortably on a couch (Group 3)
Number of subjects: 55
Study 11173127 — intervention group
Group type: EXPERIMENTAL
Intervention: Translational research in radiation oncology
Number of subjects: 0
Study 11173127 — intervention group
Group type: EXPERIMENTAL
Intervention: Translational process
Number of subjects: 0
Study 11173127 — intervention group
Group type: EXPERIMENTAL
Intervention: Future improvements in therapy
Number of subjects: 0
Study 11173127 — intervention group
Group type: EXPERIMENTAL
Intervention: Investment in translational network
Number of subjects: 0
Study 9760352 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein-carbohydrate supplement
Number of subjects: 9
Study 9760352 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 8169567 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (178 mg)
Number of subjects: 0
Study 8169567 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2851414 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg ramipril
Number of subjects: 174
Study 2851414 — intervention group
Group type: COMPARATOR
Intervention: 10 mg enalapril
Number of subjects: 174
Study 2851414 — intervention group
Group type: EXPERIMENTAL
Intervention: ramipril
Number of subjects: 174
Study 2851414 — intervention group
Group type: COMPARATOR
Intervention: enalapril
Number of subjects: 174
Study 28229502 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent singing exposure to novel play songs
Number of subjects: 64
Study 28229502 — intervention group
Group type: COMPARATOR
Intervention: Musical toy exposure to novel play songs
Number of subjects: 64
Study 26481174 — intervention group
Group type: EXPERIMENTAL
Intervention: NAVIGATE (comprehensive, multidisciplinary, team-based treatment)
Number of subjects: 404
Study 26481174 — intervention group
Group type: COMPARATOR
Intervention: Community care (usual care)
Number of subjects: 404
Study 26481174 — intervention group
Group type: EXPERIMENTAL
Intervention: NAVIGATE (for participants with duration of untreated psychosis <74 weeks)
Number of subjects: 404
Study 26481174 — intervention group
Group type: COMPARATOR
Intervention: NAVIGATE and Community care
Number of subjects: 404
Study 24168107 — intervention group
Group type: EXPERIMENTAL
Intervention: High mushroom diet (treatment B)
Number of subjects: 10
Study 24168107 — intervention group
Group type: COMPARATOR
Intervention: No mushrooms diet (treatment A)
Number of subjects: 10
Study 22794203 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-visit endodontic treatment
Number of subjects: 20
Study 22794203 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-visit endodontic treatment with calcium hydroxide medication
Number of subjects: 20
Study 20004464 — intervention group
Group type: COMPARATOR
Intervention: Clinically driven monitoring (CDM)
Number of subjects: 3321
Study 20004464 — intervention group
Group type: EXPERIMENTAL
Intervention: Laboratory and clinical monitoring (LCM)
Number of subjects: 3321
Study 18308905 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive enhancement therapy
Number of subjects: 58
Study 18308905 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline foresight measures
Number of subjects: 58
Study 16051509 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Brief Pain Inventory short form (BPI-sf) used daily in patients with osteoarthritis
Number of subjects: 0
Study 16051509 — intervention group
Group type: EXPERIMENTAL
Intervention: Original Brief Pain Inventory short form (BPI-sf)
Number of subjects: 0
Study 14977302 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine gluconate
Number of subjects: 20
Study 14977302 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.25% sodium hypochlorite
Number of subjects: 20
Study 11305520 — intervention group
Group type: EXPERIMENTAL
Intervention: Torsemide 20 mg/day
Number of subjects: 46
Study 11305520 — intervention group
Group type: COMPARATOR
Intervention: Frusemide 40 mg/day
Number of subjects: 46
Study 11305520 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (Torsemide and Frusemide)
Number of subjects: 46
Study 9561978 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined modality therapy including radiotherapy (16 patients) and sequential and intraventricular chemotherapy (methotrexate in 32 patients; cytarabine in 16; thiotepa in 6). Concurrent systemic chemotherapy was given to 12 patients.
Number of subjects: 32
Study 7942676 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar system (Bitome)
Number of subjects: 100
Study 7942676 — intervention group
Group type: COMPARATOR
Intervention: Monopolar system
Number of subjects: 100
Study 3065507 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained release verapamil (Securon SR, Knoll)
Number of subjects: 0
Study 3065507 — intervention group
Group type: COMPARATOR
Intervention: Long acting propranolol (Inderal LA, ICI)
Number of subjects: 0
Study 30474107 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback with explanation
Number of subjects: 106
Study 30474107 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback without explanation
Number of subjects: 106
Study 30474107 — intervention group
Group type: EXPERIMENTAL
Intervention: No feedback
Number of subjects: 106
Study 30474107 — intervention group
Group type: COMPARATOR
Intervention: Active control
Number of subjects: 106
Study 29104103 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D (400-4800 IU/d)
Number of subjects: 100
Study 29104103 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 28513877 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinus rhythm with heart rate increase
Number of subjects: 2539
Study 28513877 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinus rhythm in the highest heart rate quartile (>90 bpm)
Number of subjects: 2539
Study 28513877 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial fibrillation (AF) with heart rate increase
Number of subjects: 2539
Study 28513877 — intervention group
Group type: COMPARATOR
Intervention: Bisoprolol allocation
Number of subjects: 2539
Study 26283758 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel plus aspirin
Number of subjects: 0
Study 26283758 — intervention group
Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 0
Study 23265707 — intervention group
Group type: EXPERIMENTAL
Intervention: MBSR + usual care
Number of subjects: 336
Study 23265707 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 336
Study 22003288 — intervention group
Group type: EXPERIMENTAL
Intervention: Indacaterol 150 μg once daily
Number of subjects: 1648
Study 22003288 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1648
Study 18584198 — intervention group
Group type: EXPERIMENTAL
Intervention: Synacthen (0.25 mg, TX)
Number of subjects: 8
Study 18584198 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 8
Study 17310820 — intervention group
Group type: EXPERIMENTAL
Intervention: On‐3TC
Number of subjects: 131
Study 17310820 — intervention group
Group type: COMPARATOR
Intervention: Off‐3TC
Number of subjects: 131
Study 17310820 — intervention group
Group type: EXPERIMENTAL
Intervention: Viruses containing M1841/V
Number of subjects: 131
Study 12691395 — intervention group
Group type: EXPERIMENTAL
Intervention: EVD catheters impregnated with minocycline and rifampin
Number of subjects: 288
Study 12691395 — intervention group
Group type: COMPARATOR
Intervention: Standard untreated EVD catheters (control)
Number of subjects: 288
Study 10735892 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin 50 mg/m(2), gemcitabine 1,000 mg/m(2), and vinorelbine 25 mg/m(2) on days 1 and 8 every 3 weeks (PGV)
Number of subjects: 180
Study 10735892 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin 100 mg/m(2) on day 1 and gemcitabine 1,000 mg/m(2) on days 1, 8, and 15 every 4 weeks (PG)
Number of subjects: 180
Study 10735892 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin 120 mg/m(2) on days 1 and 29 and vinorelbine 30 mg/m(2)/wk (PV)
Number of subjects: 180
Study 9199002 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequency questionnaire
Number of subjects: 493
Study 9199002 — intervention group
Group type: COMPARATOR
Intervention: Dietary interview
Number of subjects: 493
Study 1389513 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg tamoxifen per day for 2 years
Number of subjects: 82
Study 1389513 — intervention group
Group type: COMPARATOR
Intervention: no drug treatment
Number of subjects: 82
Study 2932205 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin (serotonin antagonist) for 3 days
Number of subjects: 6
Study 2932205 — intervention group
Group type: COMPARATOR
Intervention: Control period (no medication for 3 days)
Number of subjects: 6
Study 2932205 — intervention group
Group type: EXPERIMENTAL
Intervention: Ergonovine administered in incremental doses (0.0125 mg to 0.4 mg)
Number of subjects: 6
Study 18320439 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH-a (triptorelin 0.1 mg on the day of ovum pickup, on the day of embryo transfer, and three days thereafter)
Number of subjects: 120
Study 18320439 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 30399363 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-compression reactive hyperemia (PCRH) with 1- to 4-min pressure applications of 16 to 34 kPa
Number of subjects: 15
Study 30399363 — intervention group
Group type: COMPARATOR
Intervention: Post-occlusive reactive hyperemia (PORH) with 3-min forearm cuff occlusion
Number of subjects: 15
Study 30399363 — intervention group
Group type: EXPERIMENTAL
Intervention: PCRH
Number of subjects: 15
Study 30399363 — intervention group
Group type: COMPARATOR
Intervention: PORH
Number of subjects: 15
Study 28137537 — intervention group
Group type: EXPERIMENTAL
Intervention: Peritoneal Resuscitation (PR)
Number of subjects: 103
Study 28137537 — intervention group
Group type: COMPARATOR
Intervention: Conventional Resuscitation (CR)
Number of subjects: 103
Study 25853876 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 d/wk training (G1; N=21)
Number of subjects: 118
Study 25853876 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 d/wk training (G2; N=27)
Number of subjects: 118
Study 25853876 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 d/wk training (G3; N=23)
Number of subjects: 118
Study 25853876 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG; N=47)
Number of subjects: 118
Study 24044802 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial breast irradiation (PBI) using interstitial multi-catheter high-dose-rate brachytherapy (4 Gy, twice a day for 4 days, until 32 Gy)
Number of subjects: 100
Study 24044802 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial breast irradiation (PBI) using interstitial multi-catheter high-dose-rate brachytherapy
Number of subjects: 100
Study 22053942 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypericum perforatum 900-1,500 mg/d
Number of subjects: 340
Study 22053942 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline 50-100 mg/d
Number of subjects: 340
Study 22053942 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 340
Study 19519236 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitator only intervention
Number of subjects: 77
Study 19519236 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer and facilitator intervention
Number of subjects: 77
Study 19519236 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 77
Study 16773482 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoanalytically oriented psychotherapy lasting for six weeks
Number of subjects: 20
Study 15376564 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic therapy plus octreotide 50 microg/h bolus and continuous infusion for 5 days (n=36)
Number of subjects: 92
Study 15376564 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide 50 microg/h bolus and continuous infusion for 5 days (n=13)
Number of subjects: 92
Study 15376564 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic therapy only (banding and/or sclerotherapy) (n=43)
Number of subjects: 92
Study 11783824 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal biopsychosocial treatments including cognitive-behavioral and/or behavioral components
Number of subjects: 21
Study 11783824 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromyogram feedback
Number of subjects: 21